Clinical Characterization of E-Cigarette, or Vaping, Product Use-associated Lung Injury in 36 Patients in Pittsburgh, Pennsylvania
- PMID: 32023422
- PMCID: PMC7233355
- DOI: 10.1164/rccm.202001-0079LE
Clinical Characterization of E-Cigarette, or Vaping, Product Use-associated Lung Injury in 36 Patients in Pittsburgh, Pennsylvania
Figures
References
-
- Evans ME, Twentyman E, Click ES, Goodman AB, Weissman DN, Kiernan E, et al. Update: interim guidance for health care professionals evaluating and caring for patients with suspected E-cigarette, or vaping, product use–associated lung injury and for reducing the risk for rehospitalization and death following hospital discharge — United States, December 2019. MMWR Morb Mortal Wkly Rep. 2020;68:1189–1194. - PMC - PubMed
-
- Carlos WG, Crotty Alexander LE, Gross JE, Dela Cruz CS, Keller JM, Pasnick S, et al. ATS health alert—vaping-associated pulmonary illness (VAPI) Am J Respir Crit Care Med. 2019;200:P15–P16. - PubMed
-
- Jatlaoui TC. Centers for Disease Control and Prevention; 2019. Outbreak of lung injury associated with e-cigarette product use or vaping: information for clinicians. [accessed 2019 Dec 20]. Available from: https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-d....
-
- Triantafyllou GA, Tiberio PJ, Zou RH, Lamberty PE, Lynch MJ, Kreit JW, et al. Vaping-associated acute lung injury: a case series. Am J Respir Crit Care Med. 2019;200:1430–1431. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
